CANCER REHABILITATION
Principles of Cancer rehabilitation. Garden FH, Grabois M, editors. Principles of
Rehabilitation Medicine: State of the art rev. 1994; Chapter 71, Section 21; 971-985
Central nervous system injury by therapeutic irradiation. Dropcho EJ: Neurol Clin1991; 9: 969-88.
Neurologic pain syndromes in patients with cancer. Elliot K, Foley KM. Neurol Clin. 1989; 7: 333-60.
Pain rehabilitation. 3. cancer pain, pelvic pain, and age-related considerations.
Williams FH, Maly BJ. Arch Phys Med Rehabil. 1994; 75:S-15-6.
The treatment of cancer pain. Foley KM. N Engl J Med 1985;313: 84-95
Brain metastases. Patchell RA. Neurol Clin. 1991; 9: 817-24.
Extradural spinal cord compressions: analysis of factors determining functional
prognosis: prospective study. Radiology. Kim RY, Spencer SA, et al. 1990; 176: 279-82.
Surgical treatment of pathological fractures from metastatic tumor of long bones. Mandi A, Szepesi K, et al. Orthop. 1991; 14: 43-9
OTHER REHABILITATION TOPICS
MULTIPLE SCLEROSIS
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Kurtzke JF. Neurology. 1983;33(11):1444-52.
Multiple sclerosis: early prognostic guidelines. Kraft GH, Freal JE, Coryell JK, Hanan CL, Chitnis N. Arch Phys Med Rehabil. 1981;62(2):54-8.
Rehabilitation in multiple sclerosis. Erickson RP, Lie MR, Wineinger MA.
Mayo Clin Proc. 1989;64(7):818-28.
Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis.
Mueller ME, Gruenthal M, Olson WL, Olson WH. Arch Phys Med Rehabil.
1997;78(5):521-4.
Bladder dysfunction in multiple sclerosis: causes and treatment. Fowler, C. Int MS J 1994;1:99-107
Vesicourethral dysfunction and urodynamic findings in multiple sclerosis: a study of 149 cases. Gallien P, Robineau S, Nicolas B, et al. Arch Phys Med Rehabil. 1998;79(3):255-7.
Management of multiple sclerosis. Rudick RA, Cohen JA, Weinstock-Guttman B,
Kinkel RP, Ransohoff RM. N Engl J Med 1997; 337: 1604-11.
Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Multiple Sclerosis Council for Clinical Practice Guidelines.1998: Washington, DC.
Fatigue therapy in Multiple Scelrosis: results of a double-blind, randomized,
parallel trial of amantadine, pemoline, and placebo. Krupp LB, Coyle PK, Doscher NP, Miller A, et al. Neurol 1995; 45: 1956-61
Exercise and multiple sclerosis. Ponichtera-Mulcare JA. Med Sci Sports Exerc 1993; 25: 451-65
The impact of inpatient rehabilitation on progressive multiple sclerosis. Freeman JA, Landon DW, Hobart JC, Thompson AJ Ann Neurol 1997; 42: 236-44
PARKINSON'S DISEASE
Contemporary approaches to the pharmacotherapeutic management of Parkinson?s disease: an overview. Stern MB. Neurol 1997; 49: Suppl 1:S2-9.
Physical therapy and parkinson?s disease: a controlled clinical trial. Comella CL,
Stebbins GT, Brown-Toms N, Goetz CG. Neurol 1994; 44: 376-8
PERIPHERAL VASCULAR DISEASE
Pulmonary embolism in rehabilitation patients: relation to time before return to
physical therapy after diagnosis of deep vein thrombosis. Kiser TS, Stefans VA. Arch Phys Med Rehabil. 1997;78(9):942-5.
Treatment of venous thrombosis with intravenous unfractionated heparin
administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. Koopman MM, Prandoni P, Piovella F, et al. N Engl J Med. 1996;334(11):682-7. Erratum in: N Engl J Med 1997;337(17):1251.
1995 American College of Chest Physicians (ACCP) consensus guidelines on
antithrombotic therapy. Davidson B. Semin Thromb Hemost. 1996;22 Suppl 2:1-5; discussion 29-30.
Current status of anticoagulation therapy after total hip and total knee
arthroplasty. Zimlich RH, Fulbright BM, Friedman RJ. J Am Acad Orthop Surg.
1996;4(2):54-62.
Prevention of thromboembolism in spinal cord injury: role of low molecular weight heparin. Green D, Chen D, Chmiel JS, et al. Arch Phys Med Rehabil. 1994;75(3):290-2.
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. Kearon C. N Engl J Med 1999;340:901-7.
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. Kearon C, Ginsberg JS, Kovacs MJ, et al. N Engl J Med 2003;349(7):631-9.
Prolonged thromboprophylaxis with oral anticoagulants after total hip
arthroplasty. Prandoni P, Bruchi O, Sabbion P, et al. Arch Intern Med, 2002; 162:1966-1971
PRESSURE ULCERS
A multicenter study on the use of pulsed low-intensity direct current for healing chronic stage II and stage III decubitus ulcers. Wood JM, Evans PE 3rd, et al. Arch Dermatol 1993; 129(8):999-1009.
The effectiveness of preventive management in reducing the occurrence of pressure sores. Krouskop TA, Noble PC, Garber SL and Spencer WA: Journal of Rehabilitation Research and Development, 20(1): 7483, 1983.
Pressure ulcers: a review. Yarkony GM. Arch Phys Med Rehabil. 1994 ;75(8):908-17.
HIV/AIDS
HIV- related disability: assessment and management. O?Dell ME, editor. Phys Med Rehabil: State of the Art Rev. Vol 7 (Special issue) 1993.
Experience with rehabilitation in the acquired immunodeficiency syndrome.
O?Connell PG, Levinston SF. Am J Phys Med Rehabil. 1991; 70: 195-200.
Rehabilitation medicine consultation in person hospitalized with AIDS. O?Dell MW. Am J Phys Med Rehabil. 1993; 72: 90-6.
Rehabilitation in adults with human immunodeficiency virus-related diseases.
O?Dell MW, et al. Am J Phys Med Rehabil. 1992; 71: 183-90.
Neurologic manifestation of HIV infection. Simpson DM, Tagliati M. Ann Intern Med. 1993; 328: 1686-95.
Therapy for human immunodeficiency virus infection. Hirsh MS, D?Aquila RT. N
Eng J Med. 1993; 328: 1686-95.
Rehabilitation dimensions of AIDS: a review. Levinson SF. Arch Phys Med Rehabil. 1991; 72: 690-6
Disability in persons hospitalized with AIDS. O?Dell MW, et al. AM J Phys Med
Rehabil. 1991; 70: 91-5.
Measuring health-related quality of life in HIV and AIDS. Wu AW, Rubin HR.
Psychol Health. 1992; 6: 251-64.